174 related articles for article (PubMed ID: 19136612)
41. Vascular permeability in retinopathy is regulated by VEGFR2 Y949 signaling to VE-cadherin.
Smith RO; Ninchoji T; Gordon E; André H; Dejana E; Vestweber D; Kvanta A; Claesson-Welsh L
Elife; 2020 Apr; 9():. PubMed ID: 32312382
[TBL] [Abstract][Full Text] [Related]
42. Shear stress control of vascular leaks and atheromas through Tie2 activation by VE-PTP sequestration.
Shirakura K; Baluk P; Nottebaum AF; Ipe U; Peters KG; McDonald DM; Vestweber D
EMBO Mol Med; 2023 Apr; 15(4):e16128. PubMed ID: 36740996
[TBL] [Abstract][Full Text] [Related]
43. Enhanced angiogenesis and increased cardiac perfusion after myocardial infarction in protein tyrosine phosphatase 1B-deficient mice.
Besnier M; Galaup A; Nicol L; Henry JP; Coquerel D; Gueret A; Mulder P; Brakenhielm E; Thuillez C; Germain S; Richard V; Ouvrard-Pascaud A
FASEB J; 2014 Aug; 28(8):3351-61. PubMed ID: 24760754
[TBL] [Abstract][Full Text] [Related]
44. The endothelial adaptor molecule TSAd is required for VEGF-induced angiogenic sprouting through junctional c-Src activation.
Gordon EJ; Fukuhara D; Weström S; Padhan N; Sjöström EO; van Meeteren L; He L; Orsenigo F; Dejana E; Bentley K; Spurkland A; Claesson-Welsh L
Sci Signal; 2016 Jul; 9(437):ra72. PubMed ID: 27436360
[TBL] [Abstract][Full Text] [Related]
45. Targeting VE-PTP phosphatase protects the kidney from diabetic injury.
Carota IA; Kenig-Kozlovsky Y; Onay T; Scott R; Thomson BR; Souma T; Bartlett CS; Li Y; Procissi D; Ramirez V; Yamaguchi S; Tarjus A; Tanna CE; Li C; Eremina V; Vestweber D; Oladipupo SS; Breyer MD; Quaggin SE
J Exp Med; 2019 Apr; 216(4):936-949. PubMed ID: 30886059
[TBL] [Abstract][Full Text] [Related]
46. FGD5 Regulates VEGF Receptor-2 Coupling to PI3 Kinase and Receptor Recycling.
Farhan MA; Azad AK; Touret N; Murray AG
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2301-2310. PubMed ID: 29051140
[TBL] [Abstract][Full Text] [Related]
47. The Rab-effector protein RABEP2 regulates endosomal trafficking to mediate vascular endothelial growth factor receptor-2 (VEGFR2)-dependent signaling.
Kofler N; Corti F; Rivera-Molina F; Deng Y; Toomre D; Simons M
J Biol Chem; 2018 Mar; 293(13):4805-4817. PubMed ID: 29425100
[TBL] [Abstract][Full Text] [Related]
48. Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP.
Guan F; Villegas G; Teichman J; Mundel P; Tufro A
Am J Physiol Renal Physiol; 2006 Aug; 291(2):F422-8. PubMed ID: 16597608
[TBL] [Abstract][Full Text] [Related]
49. Effects of SOV-induced phosphatase inhibition and expression of protein tyrosine phosphatases in rat corneal endothelial cells.
Chen WL; Harris DL; Joyce NC
Exp Eye Res; 2005 Nov; 81(5):570-80. PubMed ID: 15950220
[TBL] [Abstract][Full Text] [Related]
50. Vascular endothelial cell-specific phosphotyrosine phosphatase (VE-PTP) activity is required for blood vessel development.
Bäumer S; Keller L; Holtmann A; Funke R; August B; Gamp A; Wolburg H; Wolburg-Buchholz K; Deutsch U; Vestweber D
Blood; 2006 Jun; 107(12):4754-62. PubMed ID: 16514057
[TBL] [Abstract][Full Text] [Related]
51. Syntenin promotes VEGF-induced VEGFR2 endocytosis and angiogenesis by increasing ephrin-B2 function in endothelial cells.
Tae N; Lee S; Kim O; Park J; Na S; Lee JH
Oncotarget; 2017 Jun; 8(24):38886-38901. PubMed ID: 28418925
[TBL] [Abstract][Full Text] [Related]
52. Diabetes-induced microvascular complications at the level of the spinal cord: a contributing factor in diabetic neuropathic pain.
Ved N; Da Vitoria Lobo ME; Bestall SM; L Vidueira C; Beazley-Long N; Ballmer-Hofer K; Hirashima M; Bates DO; Donaldson LF; Hulse RP
J Physiol; 2018 Aug; 596(16):3675-3693. PubMed ID: 29774557
[TBL] [Abstract][Full Text] [Related]
53. Targeting Tie2 for Treatment of Diabetic Retinopathy and Diabetic Macular Edema.
Campochiaro PA; Peters KG
Curr Diab Rep; 2016 Dec; 16(12):126. PubMed ID: 27778249
[TBL] [Abstract][Full Text] [Related]
54. Bis(maltolato)oxovanadium(IV) Induces Angiogenesis via Phosphorylation of VEGFR2.
Parma L; Peters HAB; Johansson ME; Gutiérrez S; Meijerink H; de Kimpe S; de Vries MR; Quax PHA
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32629855
[TBL] [Abstract][Full Text] [Related]
55. Etk/Bmx transactivates vascular endothelial growth factor 2 and recruits phosphatidylinositol 3-kinase to mediate the tumor necrosis factor-induced angiogenic pathway.
Zhang R; Xu Y; Ekman N; Wu Z; Wu J; Alitalo K; Min W
J Biol Chem; 2003 Dec; 278(51):51267-76. PubMed ID: 14532277
[TBL] [Abstract][Full Text] [Related]
56. Vascular endothelial growth factor (VEGF)-Receptor2: its biological functions, major signaling pathway, and specific ligand VEGF-E.
Shibuya M
Endothelium; 2006; 13(2):63-9. PubMed ID: 16728325
[TBL] [Abstract][Full Text] [Related]
57. Integrin alphavbeta3, requirement for VEGFR2-mediated activation of SAPK2/p38 and for Hsp90-dependent phosphorylation of focal adhesion kinase in endothelial cells activated by VEGF.
Masson-Gadais B; Houle F; Laferrière J; Huot J
Cell Stress Chaperones; 2003; 8(1):37-52. PubMed ID: 12820653
[TBL] [Abstract][Full Text] [Related]
58. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis.
Ikeda S; Ushio-Fukai M; Zuo L; Tojo T; Dikalov S; Patrushev NA; Alexander RW
Circ Res; 2005 Mar; 96(4):467-75. PubMed ID: 15692085
[TBL] [Abstract][Full Text] [Related]
59. Neuropilin-1 regulates vascular endothelial growth factor-mediated endothelial permeability.
Becker PM; Waltenberger J; Yachechko R; Mirzapoiazova T; Sham JS; Lee CG; Elias JA; Verin AD
Circ Res; 2005 Jun; 96(12):1257-65. PubMed ID: 15920019
[TBL] [Abstract][Full Text] [Related]
60. The Bartonella henselae VirB/Bep system interferes with vascular endothelial growth factor (VEGF) signalling in human vascular endothelial cells.
Scheidegger F; Quebatte M; Mistl C; Dehio C
Cell Microbiol; 2011 Mar; 13(3):419-31. PubMed ID: 21044238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
